224 related articles for article (PubMed ID: 34711370)
1. Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective.
Hubens K; Krol M; Coast J; Drummond MF; Brouwer WBF; Uyl-de Groot CA; Hakkaart-van Roijen L
Value Health; 2021 Nov; 24(11):1686-1699. PubMed ID: 34711370
[TBL] [Abstract][Full Text] [Related]
2. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.
Bouwmans C; Krol M; Severens H; Koopmanschap M; Brouwer W; Hakkaart-van Roijen L
Value Health; 2015 Sep; 18(6):753-8. PubMed ID: 26409601
[TBL] [Abstract][Full Text] [Related]
3. The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.
Kigozi J; Jowett S; Lewis M; Barton P; Coast J
Value Health; 2017 Mar; 20(3):496-506. PubMed ID: 28292496
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
Jones C; Verstappen SMM; Payne K
Appl Health Econ Health Policy; 2019 Oct; 17(5):591-613. PubMed ID: 30937837
[TBL] [Abstract][Full Text] [Related]
5. How to estimate productivity costs in economic evaluations.
Krol M; Brouwer W
Pharmacoeconomics; 2014 Apr; 32(4):335-44. PubMed ID: 24504850
[TBL] [Abstract][Full Text] [Related]
6. Productivity costs in economic evaluations: past, present, future.
Krol M; Brouwer W; Rutten F
Pharmacoeconomics; 2013 Jul; 31(7):537-49. PubMed ID: 23620213
[TBL] [Abstract][Full Text] [Related]
7. Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review.
Schnitzler L; Evers SMAA; Jackson LJ; Paulus ATG; Roberts TE
BMC Public Health; 2022 Nov; 22(1):2180. PubMed ID: 36434561
[TBL] [Abstract][Full Text] [Related]
8. A review of health-related workplace productivity loss instruments.
Lofland JH; Pizzi L; Frick KD
Pharmacoeconomics; 2004; 22(3):165-84. PubMed ID: 14871164
[TBL] [Abstract][Full Text] [Related]
9. Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method.
Landfeldt E; Zethraeus N; Lindgren P
Appl Health Econ Health Policy; 2019 Feb; 17(1):15-24. PubMed ID: 30105745
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluations of occupational health interventions from a company's perspective: a systematic review of methods to estimate the cost of health-related productivity loss.
Uegaki K; de Bruijne MC; van der Beek AJ; van Mechelen W; van Tulder MW
J Occup Rehabil; 2011 Mar; 21(1):90-9. PubMed ID: 20668923
[TBL] [Abstract][Full Text] [Related]
11. Unpaid work in health economic evaluations.
Krol M; Brouwer W
Soc Sci Med; 2015 Nov; 144():127-37. PubMed ID: 26421997
[TBL] [Abstract][Full Text] [Related]
12. Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.
Tang K
Pharmacoeconomics; 2015 Jan; 33(1):31-48. PubMed ID: 25169062
[TBL] [Abstract][Full Text] [Related]
13. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
Knies S; Severens JL; Ament AJ; Evers SM
Value Health; 2010 Aug; 13(5):519-27. PubMed ID: 20712601
[TBL] [Abstract][Full Text] [Related]
14. A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.
Krol M; Papenburg J; Tan SS; Brouwer W; Hakkaart L
Eur J Health Econ; 2016 May; 17(4):391-402. PubMed ID: 25876834
[TBL] [Abstract][Full Text] [Related]
15. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel.
Brouwer WB; Koopmanschap MA; Rutten FF
Health Econ; 1997; 6(3):253-9. PubMed ID: 9226143
[TBL] [Abstract][Full Text] [Related]
16. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA.
Braakman-Jansen LM; Taal E; Kuper IH; van de Laar MA
Rheumatology (Oxford); 2012 Feb; 51(2):354-61. PubMed ID: 22179729
[TBL] [Abstract][Full Text] [Related]
17. Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.
Yuasa A; Yonemoto N; LoPresti M; Ikeda S
Pharmacoeconomics; 2021 Jan; 39(1):81-97. PubMed ID: 33230613
[TBL] [Abstract][Full Text] [Related]
18. Presenteeism exposures and outcomes amongst hospital doctors and nurses: a systematic review.
Lui JNM; Andres EB; Johnston JM
BMC Health Serv Res; 2018 Dec; 18(1):985. PubMed ID: 30567547
[TBL] [Abstract][Full Text] [Related]
19. Measuring and valuing productivity loss due to poor health: A critical review.
Zhang W; Bansback N; Anis AH
Soc Sci Med; 2011 Jan; 72(2):185-92. PubMed ID: 21146909
[TBL] [Abstract][Full Text] [Related]
20. Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review.
Zhang W; Tocher P; L'Heureux J; Sou J; Sun H
Value Health; 2023 Jan; 26(1):123-137. PubMed ID: 35961865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
